Valby, Hovedstaden, Denmark Lundbeck is the famous Corporate Investor, which was founded in 2000.
Among the most popular portfolio startups of the fund, we may highlight benevolent.ai, Proximagen, Naurex. Among the most popular fund investment industries, there are Medical Device, Biopharma. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups.
The top amount of exits for fund were in 2015. Opposing the other organizations, this Lundbeck works on 4 percentage points more the average amount of lead investments. The typical startup value when the investment from Lundbeck is more than 1 billion dollars. The fund is generally included in less than 2 deals every year. The real fund results show that this Corporate Investor is 13 percentage points more often commits exit comparing to other companies. The high activity for fund was in 2011. The common things for fund are deals in the range of 10 - 50 millions dollars.
The typical case for the fund is to invest in rounds with 3 participants. Despite the Lundbeck, startups are often financed by PathoCapital, Latterell Venture Partners, Genesys Capital. The meaningful sponsors for the fund in investment in the same round are Woodford Investment Management, Upsher Smith Laboratories, Takeda Pharmaceutical. In the next rounds fund is usually obtained by Woodford Investment Management, Takeda Ventures, Savitr Capital.
Related Funds
| Fund Name | Location |
| Cooperathon | Canada, Montreal, Quebec |
| Decibel Partners | California, Palo Alto, United States |
| Fenghai Capital | - |
| GSM Fund | - |
| Hampstead Park Capital | - |
| Meyer Keith | - |
| Qlue | Indonesia, Jakarta, Jakarta Raya |
| Scotiabank | Canada, Ontario, Toronto |
| Sham | France, Lyon, Rhone-Alpes |
| Wichita Technology Corporation (WTC) | Kansas, United States, Wichita |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Naurex | $25M | 06 May 2014 | Illinois, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Naurex | $25M | 06 May 2014 | Illinois, United States |
